Some people using PT-141 (bremelanotide) are also on hormone therapy, and combining the two is a decision that belongs with your provider. Learn more at telos rx and always disclose every medication you take during your intake.
Combining PT-141 with hormone therapy is possible for some people, but it is always a provider decision. Disclose all medications, including any hormone therapy, during your intake. Your provider reviews your full health picture before approving any combination.
Start your intake →Why disclosure matters so much here
Hormone therapy, whether for menopause, low testosterone, gender-affirming care, or another reason, changes your underlying physiology. Any medication added on top of that needs to be considered in that context.
PT-141 is not FDA-approved. It is a compounded medication prepared by partner compounding pharmacies. Whether it is appropriate alongside your specific hormone therapy is subject to medical approval by a licensed provider, based on your complete health history.
During your PT-141 intake, list every medication and therapy you are currently using, including hormone therapy, even if you assume it is unrelated. Providers need the full picture to make an informed decision.
Leaving something out, even accidentally, removes information your provider needs. If you are ever unsure whether something counts as relevant, include it anyway and let your provider decide.
What your provider considers
Your provider looks at your complete health history, current medications, and the specific hormone therapy you are using. They consider how these pieces interact and whether adding PT-141 fits safely into your overall plan.
This assessment is individualized. There is no single answer that applies to everyone on hormone therapy, since the type, dose, and reason for that therapy vary widely from person to person.
If your provider has concerns, they will discuss them with you directly rather than simply declining without explanation. You pay nothing if declined, and approval is not guaranteed.
Key takeaway: Combining PT-141 with hormone therapy is an individualized decision. Full disclosure during intake gives your provider what they need to assess your situation properly.
If you start hormone therapy after beginning PT-141
If you are already using PT-141 and are considering starting hormone therapy, tell your care team before making that change. The same applies if your existing hormone therapy changes in any way.
A new therapy or a dose change can shift the picture your provider originally assessed. Bringing your care team into the conversation early allows them to reassess your plan with current, accurate information.
Because telos rx messaging is asynchronous, you can flag a change like this any time rather than waiting for a scheduled check-in. A US-licensed provider typically responds within hours.
Why this is not a do-it-yourself decision
It might be tempting to assume that if both medications are generally well tolerated on their own, combining them is automatically fine. That assumption skips the part where a provider actually reviews your specific situation.
Hormone levels, underlying health conditions, and other medications all factor into a safe combination decision. This is exactly the kind of judgment call that belongs with a licensed provider rather than general online information.
For general background on melanocortin receptor agonists, see this NIH-hosted pharmacology review. For how compounded medications are regulated, see the FDA overview of drug compounding.
Common reasons people are on both
People come to this combination from a range of starting points. Some are managing symptoms related to menopause and are curious whether PT-141 fits alongside their existing treatment. Others are on testosterone therapy and want to understand whether adding PT-141 makes sense for their goals.
Gender-affirming hormone therapy is another context where this question comes up. In every case, the underlying principle is the same. Your provider needs your complete picture. The decision is made for your specific situation, not a general rule applied to a category of people.
If you are also curious about other options, such as sermorelin or other peptide protocols, mention that during your intake as well. Your provider can discuss how different options might or might not fit together for you.
What not to assume
Do not assume that because a friend or partner successfully combined PT-141 with their own hormone therapy, the same will be true for you. Hormone types, doses, and underlying health conditions vary enormously between individuals.
Do not assume that stopping your hormone therapy without telling your provider is a simpler or safer path. Any change to an existing therapy should go through the provider managing that therapy. It is also worth telling your PT-141 care team about that change, since it affects the full picture they are working from.
Do not assume silence is neutral. If you are unsure whether something is worth mentioning, the safer assumption is that it is.
Questions worth asking your provider
If you are considering this combination, it helps to come prepared with specific questions. Ask what your provider will be monitoring, whether quarterly labs will look any different because of the combination, and what symptoms would warrant reaching out sooner.
Ask, too, about timing. Whether your hormone therapy and PT-141 should be taken at different times of day, or with any spacing between them, is a detail your provider can address based on your specific regimen.
Start an online visit and bring these questions with you so your provider can address them as part of your initial review.
Ongoing monitoring when combining therapies
Your PT-141 plan includes quarterly labs and ongoing provider access. When you are combining therapies, that ongoing check-in becomes even more valuable, since it gives your provider real data over time rather than a single point-in-time assessment.
Report anything unexpected promptly rather than waiting for your next scheduled lab. Early information helps your provider adjust your plan sooner if adjustment turns out to be needed.
Unlimited care-team messaging means you always have a way to flag a concern, whether it relates to PT-141, your hormone therapy, or how the two seem to be interacting for you specifically.
Working with more than one provider
Many people combining PT-141 with hormone therapy have two different providers involved, one managing the hormone therapy and one managing their PT-141 plan. That is completely normal, but it does mean communication matters more.
Consider giving each provider a general sense that you are also working with someone else on a related therapy. You do not need to coordinate every detail between them, but making sure each provider has your complete medication list helps them make better decisions.
If either provider makes a change, updating the other, even with a brief note, keeps both of them working from accurate information. This is a small habit that prevents a lot of potential confusion down the line.
Your telos rx care team is used to working alongside other providers you may see for hormone therapy or other conditions. Mentioning that context during your intake, and keeping it updated, is a normal and expected part of using this service.
How this differs from combining PT-141 with other peptides
Hormone therapy is a different category from combining PT-141 with another peptide, such as BPC-157 or NAD. Hormone therapy changes your underlying physiology in a more systemic way, which is part of why disclosure and provider review matter so much here specifically.
That said, the same basic principle applies across any combination question. Tell your provider everything you are using, and let them make the individualized call rather than assuming based on general information you have read.
If you are curious about multiple peptide protocols alongside hormone therapy, bring the full list to your intake. Your provider would rather have too much information than too little when making decisions about your care.
Timing your intake around hormone therapy changes
A hormone therapy adjustment might already be planned with your other provider. If so, mention that timeline during your PT-141 intake too. Your provider can factor an upcoming change into how they think about your plan from the start.
This is not about delaying your PT-141 intake until every other piece of your care is settled. It is about giving your provider a realistic sense of what is changing and when, so nothing catches anyone off guard later.
If a hormone therapy change happens unexpectedly, such as your other provider adjusting your regimen sooner than planned, simply message your telos rx care team as soon as you know. There is no need to wait for a scheduled check-in.
Being your own best advocate
Ultimately, you are the common thread across every provider and every therapy involved in your care. No single provider automatically knows what another provider is doing unless you tell them.
Keeping a simple, current list of everything you take, including hormone therapy, PT-141, and anything else, makes it far easier to share accurate information quickly whenever a provider asks. Update that list whenever something changes, rather than trying to reconstruct it from memory during an appointment.
This habit protects you more than it protects any single provider's paperwork. A complete, accurate picture is the foundation every good decision about your care is built on. It is a habit worth keeping no matter how many providers you are currently working with, today or in the future.
Frequently Asked Questions
Can I use PT-141 while on hormone therapy?
Possibly, depending on your specific situation. This is a decision your provider makes after reviewing your complete health history and current medications.
Do I need to disclose my hormone therapy during intake?
Yes, always disclose every medication and therapy you use, including hormone therapy, even if you are not sure it is relevant.
What if I start hormone therapy after already using PT-141?
Tell your care team before making the change. A new therapy can shift the picture your provider originally assessed.
Will combining therapies change my monitoring?
Your provider may adjust what they monitor based on your specific combination. Quarterly labs and ongoing access are part of your plan either way.
Can I decide on my own that a combination is safe?
No. This is an individualized clinical decision that requires your provider's review of your full health picture.
What if my provider has concerns about combining therapies?
They will discuss those concerns with you directly. You pay nothing if declined, and any approval remains subject to medical review.
telos rx is LegitScript-certified. PT-141 is not FDA-approved and is prepared by partner compounding pharmacies. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Have questions about your specific situation? Message the telos rx care team or start your evaluation at telos rx.